dividends
RP
NASDAQ · RPRX
Royalty Pharma plc
Healthcare · Biotechnology
$63.96
Up+$0.08 (+0.13%)
Updated Sep 7, 2026, 12:22 PM
SID Score
7.4/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 16.85B
- P/E ratio
- 16.44
- Dividend yield
- 1.38%
- 52-week range
- $34.08 – $64.38
- Volume
- 3.4M
- Avg. volume
- 4.22M
Price performance
RPRX price history
1M range · 20 trading sessions · Daily adjusted prices
RPRX closed at $63.96 after 20 trading sessions, up 10.33% for the selected period.
- Last close
- $63.96
- Period change
- +10.33%
- Period low
- $57.79
- Period high
- $63.96
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 4, 2026 | $63.55 | $64.38 | $63.43 | $63.96 | 3.4M |
| Sep 3, 2026 | $63.565 | $63.94 | $62.50 | $63.88 | 2.76M |
| Sep 2, 2026 | $62.66 | $63.285 | $62.03 | $63.11 | 3.14M |
| Sep 1, 2026 | $61.815 | $62.58 | $61.61 | $62.32 | 2.63M |
| Aug 31, 2026 | $60.805 | $61.68 | $60.39 | $61.41 | 3.9M |
| Aug 28, 2026 | $61.92 | $62.01 | $60.6553 | $60.85 | 1.7M |
| Aug 27, 2026 | $61.42 | $62.35 | $61.01 | $61.92 | 2.09M |
| Aug 26, 2026 | $62.04 | $62.28 | $61.49 | $61.80 | 1.48M |
| Aug 25, 2026 | $61.33 | $62.455 | $60.87 | $62.07 | 1.71M |
| Aug 24, 2026 | $61.19 | $61.54 | $60.8043 | $61.33 | 2.36M |
| Aug 21, 2026 | $60.53 | $61.60 | $60.37 | $61.31 | 2.33M |
| Aug 20, 2026 | $61.33 | $62.13 | $60.37 | $60.58 | 3.14M |
| Aug 19, 2026 | $60.12 | $61.80 | $59.75 | $61.73 | 3.26M |
| Aug 18, 2026 | $59.74 | $60.42 | $59.655 | $59.69 | 2.08M |
| Aug 17, 2026 | $58.36 | $59.49 | $58.18 | $59.45 | 2.36M |
| Aug 14, 2026 | $57.89 | $58.78 | $57.72 | $58.60 | 1.6M |
| Aug 13, 2026 | $59.50 | $59.58 | $57.945 | $58.56 | 2.52M |
| Aug 12, 2026 | $57.75 | $59.33 | $57.65 | $59.22 | 3.92M |
| Aug 11, 2026 | $58.04 | $58.63 | $57.76 | $57.79 | 2.39M |
| Aug 10, 2026 | $57.43 | $58.03 | $56.5301 | $57.97 | 4.26M |
Latest RPRX news
The latest Smart Investors Daily articles mentioning RPRX.
Stock researchCompany · Forecast
Loading stock research…

